colforsin has been researched along with glucagon-like peptide 2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanafusa, T; Kuwajima, M; Matsumura, T; Matsuzawa, Y; Miki, H; Mineo, I; Miyagawa, J; Nakajima, H; Namba, M; Nishimura, T | 1 |
Boushey, RP; Drucker, DJ; Yusta, B | 1 |
Andersen, M; Hastrup, S; Sams, A; Thim, L | 1 |
Hyland, NP; Lomax, AE; Mawe, GM; O'Hara, JR; Sharkey, KA | 1 |
Acitores, A; Esbrit, P; González, N; López-Herradón, A; Moreno, P; Nuche-Berenguer, B; Portal-Núñez, S; Valverde, I; Villanueva-Peñacarrillo, ML | 1 |
5 other study(ies) available for colforsin and glucagon-like peptide 2
Article | Year |
---|---|
Glucagon-like peptide-1(7-36)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes.
Topics: 1-Methyl-3-isobutylxanthine; Adipocytes; Animals; Colforsin; Cyclic AMP; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptides; Glucose; Insulin; Male; Peptide Fragments; Peptides; Phosphodiesterase Inhibitors; Rats | 1996 |
The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Division; Cell Line; Cell Survival; Chromones; Colforsin; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Cycloheximide; Cysteine Proteinase Inhibitors; Cytochrome c Group; Cytosol; DNA Fragmentation; Electrophoresis, Agar Gel; Enzyme Activation; Enzyme Inhibitors; Epithelium; Fibroblasts; Flavonoids; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptides; Intestinal Mucosa; Isoquinolines; Microscopy, Fluorescence; Mitochondria; Morpholines; Peptides; Poly(ADP-ribose) Polymerases; Protein Synthesis Inhibitors; Receptors, Cell Surface; Receptors, Glucagon; Signal Transduction; Sulfonamides; Time Factors; Transfection | 2000 |
Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines.
Topics: Animals; Binding, Competitive; Blotting, Western; Caco-2 Cells; Calcium; Cell Line; Cell Line, Tumor; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Epithelial Cells; Fibroblasts; Gene Expression; Glucagon-Like Peptide 2; Glucagon-Like Peptide-2 Receptor; Glucagon-Like Peptides; Humans; Intestinal Mucosa; Intestines; Receptors, Glucagon; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2006 |
Persistent alterations to enteric neural signaling in the guinea pig colon following the resolution of colitis.
Topics: Action Potentials; Animals; Bethanechol; Body Weight; Cell Count; Colforsin; Colitis; Colon; Enteric Nervous System; Enteroendocrine Cells; Excitatory Postsynaptic Potentials; Glucagon-Like Peptide 2; Guinea Pigs; Male; Membrane Potentials; Neurons; Peptide YY; Peroxidase; Serotonin; Serotonin Plasma Membrane Transport Proteins; Submucous Plexus; Tetrodotoxin; Trinitrobenzenesulfonic Acid; Veratridine | 2007 |
Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor.
Topics: 3T3 Cells; Adenylyl Cyclases; Animals; Colforsin; Cyclic AMP; Exenatide; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Humans; Mice; Osteoblasts; Parathyroid Hormone; Peptides; Protein Binding; Rats; Receptors, Glucagon; Venoms | 2010 |